Characterization of new DOPC/DHPC platform for dermal applications
Gelen Rodríguez1, Laia Rubio, Clara Barba
1Department of Chemical and Surfactant Technology, Institute of Advanced Chemistry of Catalonia, IQAC-CSIC, C/Jordi Girona 18-26, 08034, Barcelona, Spain. gelen.rodriguez@cid.csic.es
European Biophysics Journal : EBJ
|December 28, 2012
Summary
DOPC/DHPC phospholipid mixtures form nanostructures that alter skin properties. These systems reduce skin permeability and hydration by inducing microstructural changes.
Area of Science:
- Physical Chemistry
- Materials Science
- Biophysics
Background:
- Phospholipid mixtures are crucial for developing advanced materials.
- Understanding nanostructure self-assembly is key to controlling material properties.
- The interaction of phospholipids with biological tissues, like skin, requires detailed investigation.
Purpose of the Study:
- To characterize nanostructures formed by dioleoylphosphatidylcholine (DOPC) and dihexanoylphosphatidylcholine (DHPC) mixtures.
- To investigate the self-assembly, morphology, and thermotropic behavior of these phospholipid systems.
- To evaluate the in vivo effects of DOPC/DHPC systems on skin biophysical parameters.
Main Methods:
- Differential scanning calorimetry (DSC)
- Small-angle X-ray scattering (SAXS)
- Freeze fracture electron microscopy (FFEM)
- Cryogenic transmission electron microscopy (Cryo-TEM)
Main Results:
- DOPC/DHPC mixtures formed aggregates with altered membrane thickness and flexibility.
- Electron microscopy revealed distinct nanostructure sizes and morphologies.
- In vivo studies showed that DOPC/DHPC application decreased skin permeability and hydration.
Conclusions:
- DOPC/DHPC phospholipid mixtures self-assemble into nanostructures with unique properties.
- These nanostructures induce significant changes in skin biophysical parameters, reducing permeability and hydration.
- The findings provide insights into the interaction mechanisms between phospholipid systems and skin tissue.
Related Concept Videos
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:11Papillary Dermis
Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...